NRX Pharmaceuticals, Inc. SEC filings NRXP
NRX Pharmaceuticals, Inc. has 477 filings in SEC EDGAR's recent list, going back to Oct 13, 2017. Its latest annual report, Form 10-K, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jun 3, 2026 | — |
| 424B5 | Prospectus supplement | Jun 2, 2026 | — |
| 424B5 | Prospectus supplement | Feb 17, 2026 | — |
| 424B3 | Prospectus | Dec 22, 2025 | — |
| S-3/A | Form s-3/a | Dec 12, 2025 | — |
| 424B5 | Prospectus supplement | Aug 18, 2025 | — |
| S-3 | Shelf registration | Jun 20, 2025 | — |
| 424B3 | Prospectus | Apr 17, 2025 | — |
| 424B3 | Prospectus | Feb 20, 2025 | — |
| 424B3 | Prospectus | Jan 29, 2025 | — |
| S-1 | Registration statement | Nov 14, 2024 | — |
| 424B3 | Prospectus | Aug 15, 2024 | — |
| 424B3 | Prospectus | Aug 14, 2024 | — |
| 424B3 | Prospectus | Jul 5, 2024 | — |
| 424B5 | Prospectus supplement | Apr 19, 2024 | — |
| 424B5 | Prospectus supplement | Apr 18, 2024 | — |
| 424B3 | Prospectus | Apr 15, 2024 | — |
| 424B3 | Prospectus | Apr 15, 2024 | — |
| 424B5 | Prospectus supplement | Feb 28, 2024 | — |
| 424B5 | Prospectus supplement | Feb 26, 2024 | — |
| 424B3 | Prospectus | Aug 31, 2023 | — |
| 424B5 | Prospectus supplement | Aug 14, 2023 | — |
| 424B5 | Prospectus supplement | Jun 8, 2023 | — |
| 424B5 | Prospectus supplement | Mar 14, 2023 | — |
| 424B5 | Prospectus supplement | Mar 10, 2023 | — |
| 424B5 | Prospectus supplement | Dec 2, 2022 | — |
| 424B7 | Form 424b7 | Jul 25, 2022 | — |
| S-3/A | Filing | Jun 14, 2022 | — |
| 424B3 | Prospectus | Jun 13, 2022 | — |
| S-3 | Shelf registration | Jun 9, 2022 | — |
| POS AM | Filing | Jun 8, 2022 | — |
| 424B3 | Prospectus | Jun 8, 2022 | — |
| 424B3 | Prospectus | Jun 8, 2022 | — |
| 424B3 | Prospectus | Jun 8, 2022 | — |
| 424B3 | Prospectus | Jun 1, 2022 | — |
| 424B3 | Prospectus | Jun 1, 2022 | — |
| 424B3 | Prospectus | Jun 1, 2022 | — |
| 424B3 | Prospectus | May 18, 2022 | — |
| 424B5 | Prospectus supplement | May 5, 2022 | — |
| 424B5 | Prospectus supplement | May 5, 2022 | — |
| POS AM | Form pos am | Apr 29, 2022 | — |
| POS AM | Filing | Apr 29, 2022 | — |
| 424B3 | Prospectus | Apr 20, 2022 | — |
| S-1 | Registration statement | Apr 8, 2022 | — |
| 424B3 | Prospectus | Apr 1, 2022 | — |
| 424B3 | Prospectus | Apr 1, 2022 | — |
| 424B3 | Prospectus | Mar 18, 2022 | — |
| 424B3 | Prospectus | Mar 18, 2022 | — |
| 424B3 | Prospectus | Mar 9, 2022 | — |
| 424B3 | Prospectus | Mar 9, 2022 | — |
| 424B3 | Prospectus | Mar 3, 2022 | — |
| 424B3 | Prospectus | Mar 3, 2022 | — |
| 424B3 | Prospectus | Mar 3, 2022 | — |
| 424B3 | Prospectus | Mar 3, 2022 | — |
| 424B3 | Prospectus | Feb 25, 2022 | — |
| 424B3 | Prospectus | Feb 25, 2022 | — |
| 424B3 | Prospectus | Nov 18, 2021 | — |
| 424B3 | Prospectus | Nov 18, 2021 | — |
| 424B3 | Prospectus | Oct 21, 2021 | — |
| 424B3 | Prospectus | Oct 21, 2021 | — |
| 424B3 | Prospectus | Oct 15, 2021 | — |
| 424B3 | Prospectus | Oct 15, 2021 | — |
| 424B3 | Prospectus | Sep 15, 2021 | — |
| 424B3 | Prospectus | Sep 10, 2021 | — |
| S-1 | Registration statement | Sep 3, 2021 | — |
| 424B3 | Prospectus | Aug 24, 2021 | — |
| 424B3 | Prospectus | Aug 20, 2021 | — |
| 424B3 | Prospectus | Aug 17, 2021 | — |
| S-8 | Employee stock plan registration | Jul 29, 2021 | — |
| 424B3 | Prospectus | Jul 12, 2021 | — |
| S-1/A | Amended registration statement | Jul 6, 2021 | — |
| S-1 | Registration statement | Jun 25, 2021 | — |
| 424B3 | Prospectus | May 21, 2021 | — |
| S-4/A | Filing | May 21, 2021 | — |
| S-4/A | Filing | May 20, 2021 | — |
| S-4/A | Filing | May 19, 2021 | — |
| S-4/A | Filing | May 12, 2021 | — |
| S-4/A | Filing | Apr 16, 2021 | — |
| S-4 | Registration for a merger or exchange | Jan 27, 2021 | — |
| 424B4 | Prospectus | Nov 21, 2017 | — |
| S-1MEF | Filing | Nov 20, 2017 | — |
| S-1/A | Amended registration statement | Nov 20, 2017 | — |
| S-1/A | Amended registration statement | Nov 17, 2017 | — |
| S-1/A | Amended registration statement | Nov 14, 2017 | — |
| S-1 | Registration statement | Oct 13, 2017 | — |
Showing 85 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NRXP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1719406
- Former names
- Big Rock Partners Acquisition Corp. (until May 24, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.